Filing Details
- Accession Number:
- 0001209191-21-070352
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-17 17:20:12
- Reporting Period:
- 2021-12-15
- Accepted Time:
- 2021-12-17 17:20:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1678660 | Prelude Therapeutics Inc | PRLD | Pharmaceutical Preparations (2834) | 811384762 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1824625 | Deborah Morosini | C/O Prelude Therapeutics Incorporated 200 Powder Mill Road Wilmington DE 19803 | Evp, Chief Of Clinical Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-15 | 3,016 | $1.89 | 3,460 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-12-15 | 25,735 | $12.85 | 29,195 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-12-15 | 28,751 | $13.00 | 444 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-12-15 | 3,016 | $0.00 | 3,016 | $1.89 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-12-15 | 24,853 | $0.00 | 24,853 | $12.85 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-12-15 | 882 | $0.00 | 882 | $12.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,307 | 2030-03-26 | No | 4 | M | Direct | |
| 74,575 | 2030-09-01 | No | 4 | M | Direct | |
| 195,163 | 2030-09-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The stock option is fully vested.
- The stock option vests as to 25% of the total shares monthly beginning on September 24, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
- The stock option vests as to 25% of the total shares monthly beginning on July 27, 2020, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
Billionaire Hedge Funds
